F5 Networks Earnings Preview

F5 Networks (NASDAQ:FFIV) is set to give its latest quarterly earnings report on Monday, 2022-07-25. Here's what investors need to know before the announcement. Analysts estimate that F5 Networks will report an earnings per share (EPS) of $2.24.

F5 Networks (NASDAQ:FFIV) is set to give its latest quarterly earnings report on Monday, 2022-07-25. Here’s what investors need to know before the announcement.

Analysts estimate that F5 Networks will report an earnings per share (EPS) of $2.24.

F5 Networks bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.12, which was followed by a 12.84% drop in the share price the next day.

Here’s a look at F5 Networks’s past performance and the resulting price change:

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 2.01 2.78 2.75 2.46
EPS Actual 2.13 2.89 3.01 2.76
Price Change % -12.84% -8.43% 5.94% 6.2%

eps graph

Stock Performance

Shares of F5 Networks were trading at $156.83 as of July 21. Over the last 52-week period, shares are down 19.5%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for F5 Networks visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

XP Earnings Preview

  XP (NASDAQ:XP) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that XP will report an earnings per share (EPS) of $0.32.

XP

Read More

Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss

Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68% year-over-year increase in revenues for the first half of fiscal 2024, a metrics CFO Nicholas Sosiak called "a testament to our growing influence in the Quebec, Ontario, Alberta, and BC markets." "Our proactive steps towards streamlining assets align with our ambition to fortify our financial foundation as we relentlessly stay focused on gaining market share and becoming the leader in Canada, the second-largest cannabis market in the world," Sosiak said. "As for our long-term vision, we do see our future extend beyond our borders where Cannara is a globally recognized brand synonymous with excellence and value in cannabis."

LOVE